ASCO 2024: Artificial Intelligence: Innovation and Potential for Diagnostic Imaging in Prostate Cancer

ASCO 2024, Prostate Cancer, Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography (PSMA-PET), Diagnostic Imaging in Prostate Cancer, Artificial Intelligence in diagnostics, Innovation and Potential for Diagnostic Imaging in Prostate Cancer, PI-RADS guidelines.

Related Keywords

United States ,Chicago ,Illinois ,Georgia ,American ,Zachary Klaassen ,Stephaniea Harmon ,Stephanie Harmon ,Twitter ,American Society Of Clinical Oncology ,Molecular Imaging Program ,Georgia Cancer Center ,National Cancer Institute ,Clinical Oncology ,Prostate Imaging Reporting ,Data System ,Staff Scientist ,Urologic Oncologist ,Associate Professor ,Annual Meeting ,